ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000479.1|Prenylagaramide_1 # 1 # 198 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.389	BGC0000479.1|Prenylagaramide_1 	1	198	-	Loose	550	23.0978	LRA-12	29.55	3002511	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	ATGAGCGAAGAAAAGAAGACAACGGCAAAAAATAAAGTGACTAAATCTGTTGGTAAACCCGAAAAAAAAGAAATTCAACAAGATTGTATGATGACTGGACTTTCGGATTATGGTTTTTGGTCACAAAAGGTTAAAGAAGAAGTTGCAGCCCGAAAAGAGCCTGATGCTCCTTTCCGTCGGGGTCGAATTTGGTGTTAG	MSEEKKTTAKNKVTKSVGKPEKKEIQQDCMMTGLSDYGFWSQKVKEEVAARKEPDAPFRRGRIWC	MNVQNCMVKAVSVSIILFASLSLAAQKVKEPTVSNADWSKPYRPFRIAGNLYYIGTYDLACYLITTKQGNIIVNTGLAASALQIKNNIKALGFKLTDTKILLTTQAHYDHLGAMAEIKKITGAKLMADEGDATVMADGGSSDYAFGGHGSMFEPIIADRLLHDKDTIQLGDTKLVMLHHPGHTKGSCSFLFDTKDEQRSYRILIANMPTIVIEKKFSEVSSYPGIAKDYAYTLQAMKNLSFDIWVASHASQFSMHSKHKPGDGYNPKSFMDRKGYDESLDKLQKEYEKHLNEN	22.18	gnl|BL_ORD_ID|9|hsp_num:0	13			9	141	
BGC0000479.1|Prenylagaramide_2 # 246 # 455 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.386	BGC0000479.1|Prenylagaramide_2 	246	455	-	Loose	2070	27.7202	smeE	30.95	3003056	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGATTACCTAACCTTTCCCCTCCAGTCAAAAGACCTGATGTTATTTATCCCCATCGCTCTGTAGATGTGGTTAACGGAACAGAAGAAGAATTACTTAGTATTAGATTGAAATTATTACACGGTGCAAATTACAATGATCCGGCGGCTTTTGCTCACAGAAGCTATCAACAACTTAAGTCTTCTGGTAGTTGTGGATGTGGATTTTAA	MRLPNLSPPVKRPDVIYPHRSVDVVNGTEEELLSIRLKLLHGANYNDPAAFAHRSYQQLKSSGSCGCGF	MARFFIDRPIFAWVIAIIIMLAGGLALFKLPVSMYPNVAPPAVEISATYPGASAKVVEDSVTQIIEQNMKGLDGLIYFSSNSSSNGQATITLTFESGTNPDIAQVQVQNKLQLAMPLLPQEVQRQGINVAKSSSGFLNAIAFVSENGSMDANDIADYVGSNVVDRLSRVPGVGNIQVFGGKYAMRIWLDPNKLHTYGLSVPEVTAAIKAQNAQVAIGQLGGAPSVKGQQLNATINAQSRLQTPEQFRNIIVRGAQDGAELRLGDVARVELGAESYDFVTRYNGQPASGLAVTLATGANALDTAAGVDAALEDMKGFFPAGLKAEIPYDTTPFVRVSIKGVVQTLIEAIVLVFVVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAMLGFSVNMLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPLEATRKSMGQITGALVGIGLVLSAVFVPMAFMSGSTGVIYRQFSATIVSAMALSVLVAIVLTPALCATMLKPLKKGEHHVAHRGLAGRFFNGFNRGFDRTSESYQRGVRGIIHRPWRFMGIVAALFVLMGVLFVRLPSSFLPNEDQGVLMALVQAPVGATQERTLESIAALENHFLQNEKDAVDSVFSVQGFSFAGMGQNAGMAFVKLKDWSERDADNGVMPITGRAMAALGQIKDAFIFAFPPPAIPELGTASGYTFFLKDNSGQGHEALVAARNQLLGLAAGSKKLANVRPNGQEDTPQFRIDIDAAKATSLGLSIDQINGTLAAAWGSSYIDDFVDRGRVKRVFVQADQAFRMVPEDFDLWSVKNDKGEMVPFSAFATKHWDYGSPRLERYNGVSAMEIQGEPAPGVASGDAMAEIEQLAKQLPAGFGIEWTAMSYQERQAGSQTPLLYTLSLMIVFLCLAAMYESWSVPTAVLLAAPLGILGAVLANTFKGLERDIYFQVAMLTTVGLTSKNAILIVEFAKENLEKGASLIESIMHAVRDRLRPIVMTSLAFGMGVVPLAISTGAGSGAKQAIGTGVLGGMIVGTVLGVFFVPLFFVVVQRVFKRRSTT	6.63	gnl|BL_ORD_ID|807|hsp_num:0	876			105	231	tetracycline; chloramphenicol
BGC0000479.1|Prenylagaramide_4 # 2608 # 2997 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.336	BGC0000479.1|Prenylagaramide_4 	2608	2997	-	Loose	400	26.5646	CRP	28.87	3000518	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCGAACTTTATAACAGAAATTCTGAAAAAGAGAAACGACAATTTTTACGCAATAACATGACTCCTGCGGAACAAAAATTGTGGTTACAACTTAAAGGAAAGCAATTAGAAAACTGTAAATTTCGGCGACAATATAGTGTAGCTCAATTTATTATTGATTTTTATAGCCCAGAAATTAAACTTGCTATTGAAGTTGATGGCGACAGTCATTTTCAAGAAGGAGTGCAAGAATACGACCAAGAAAGACAACAGTTTATCGAGTCAGCTAGAATTACTTTTCTGAGGTTTACCAATGATGACGTATATGATAATATTTCAGCAGTTTGTGAAATCATCAGAGATAAAATTCAATCCTTGAGAAATCTTCCAGAAGCTCCCCCTTACTAA	MTELYNRNSEKEKRQFLRNNMTPAEQKLWLQLKGKQLENCKFRRQYSVAQFIIDFYSPEIKLAIEVDGDSHFQEGVQEYDQERQQFIESARITFLRFTNDDVYDNISAVCEIIRDKIQSLRNLPEAPPY	MVLGKPQTDPTLEWFLSHCHIHKYPSKSKLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	61.43	gnl|BL_ORD_ID|803|hsp_num:0	869			72	357	erythromycin; cloxacillin; oxacillin; norfloxacin
BGC0000479.1|Prenylagaramide_5 # 3295 # 3873 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.347	BGC0000479.1|Prenylagaramide_5 	3295	3873	-	Loose	1800	25.7942	mdtC	40.74	3000794	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTAATCACGAAACCCCGCTTTCAAACTTTTGCTGAGTATTTACAATATGACGATAATTCAGAAAAACTCTGTGAATTATTTAATGGAGAATTGGTAGAAATGCCTCCAGAATCTGGACTTAACTTTCAAATTGCTAATCGCCTTTTTTTGGTTTTTGCTTTAATACTAGGAACTGATAGAGTTAGAGGTCATGGCTTAGAATTAGAAGTCAGAGGTGAACCGAAAAACCGTTACCCTAATTTGACCATTATTCGAGAAGAACATATTCAATTACTCTCCAAGAGAAATACCATTCTTCTTTCCATGTCACCACCTTTATTAGTCATTGAAGTGGTTAGTCCTGGAGAAATTCAAAGAGAAAGAGATTACATCGCCAAAAAATTACAATATCAAGATTGTAGCATTCCCGAATACTGGATTGTTGATCCTCAAACTCAAACCATTTTAGTCTTAGAACTAACTGGAGATACCTATAGGGAAATCGGTAATTTTACCAACGATGATTTAGTTGCCTCTCCTGGACTTAAAGAATTAAACTTAAAAGTCTCCGAGGTATTTAATTCAACCAGTTTATAA	MLITKPRFQTFAEYLQYDDNSEKLCELFNGELVEMPPESGLNFQIANRLFLVFALILGTDRVRGHGLELEVRGEPKNRYPNLTIIREEHIQLLSKRNTILLSMSPPLLVIEVVSPGEIQRERDYIAKKLQYQDCSIPEYWIVDPQTQTILVLELTGDTYREIGNFTNDDLVASPGLKELNLKVSEVFNSTSL	MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE	18.73	gnl|BL_ORD_ID|1212|hsp_num:0	1315			372	453	novobiocin
BGC0000479.1|Prenylagaramide_6 # 3873 # 4775 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.323	BGC0000479.1|Prenylagaramide_6 	3873	4775	-	Loose	680	26.9498	LpeA	56.0	3004099	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATAGTTAATGTAATCCAAAAAGACAGACTCAAAGAACAAAAACTACAGTTTATTCGCAATCATCAACAAGCTTTTGACGTTGAGCCAATTTATCCGCTCCCCTTATTTGAAGACTTTGTAACGAGCATTGAAGGTGACTGTAGCCTTGAAGCATCTTGTAAAATAGAATCAGACAAATTGATTGCCTCAAGATTTCTGCTTTTTTTTGAAGATAAAACACAAGAATGGCAAAAATATCTCCATCAATCTTTGACATTTTTTGGCCTGGTAGAAAACCGTGTTGGTGTGAAAATCAACTATTCTTTGTTACAGCAATTTTTAGGATCTAGTTTTGATTTTAGTAAAGTTACCGTTCTTTCTGCGGGGATTGACTTAAGAAACAATCTGGCTGAATCTAGCTTAAAAATGCACATTAGAATCAAAGATTATCCCGAAAAGTTGGATAAAGCTTTTGCCTTAAGTGATGGTGCGGCGGATGGTAATTACCTGAAAGATTTTGTCAACTTGATTGGTTTTGATTTTTATTTTAATGGTAAAAGTGAAATAGAAATTTATGCCGAAGTGCAAGAAGATGATTTTTTCAAACCAGAAATTAATAACTTAGTATGGCAACACTTCCCCAAAACAGCCTTACAACCTCTGAAAGCTTCAAGTTTATTTTTTACGGGTTTGTCTAAAGCAAATAATAATCCAGTTCTCTATTATCATCTTAAAAATAGACAAGATTTAACTAATTATTTTAAACTCAACGATACCGCTCAACGAGTTCACAGCTTTTATCAACATCAAGATATATTACCTTATATGTGGGTAGGTACTGCCCAAAAAGAATTAGAAAAAACAAGAATAGAAAATATTAGACTGTATTATTACAAATCATTTAAAATGGAGTCAAATTGA	MIVNVIQKDRLKEQKLQFIRNHQQAFDVEPIYPLPLFEDFVTSIEGDCSLEASCKIESDKLIASRFLLFFEDKTQEWQKYLHQSLTFFGLVENRVGVKINYSLLQQFLGSSFDFSKVTVLSAGIDLRNNLAESSLKMHIRIKDYPEKLDKAFALSDGAADGNYLKDFVNLIGFDFYFNGKSEIEIYAEVQEDDFFKPEINNLVWQHFPKTALQPLKASSLFFTGLSKANNNPVLYYHLKNRQDLTNYFKLNDTAQRVHSFYQHQDILPYMWVGTAQKELEKTRIENIRLYYYKSFKMESN	MLGIQFNRGQWRSNYYWQIPVLIIAVISILFFISKKLFYSKVTPESIPNKLVEVEPIKSHNLQQTIHLLGTIHPKHATTLIAKESGMLDTLIPTGQKVTKGTLIAKINNPDLEKNLQLSLSAVELAKAQYERITPLIKSGYVSTKEVEEKKQAWIDAQKELSKTRIELDNLRFYAPFDGIIGAYKKREGAQVNAGESVVSIYDPSALVVDFDIPCSNLATLNEGQPVYVLGKRYSLSHLQKMLDEDTHMCPADVDIQCDDCLIGATTSVELLVAEKNNTIVIPFQAIFLRNSKPFVYLVKKGKIVLASVKTGLQQEDKIEIVEGLKAGQQLVTKGQERLYPEMTVDIYHPATSSS	84.51	gnl|BL_ORD_ID|2386|hsp_num:0	2758			459	531	erythromycin; spiramycin; azithromycin
BGC0000479.1|Prenylagaramide_7 # 4806 # 5621 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.434	BGC0000479.1|Prenylagaramide_7 	4806	5621	+	Loose	1200	30.8018	arnA	32.43	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCCTAGAAAACCTCGAAATTTACAGTCTGGATATTCTTACCATATTACCATCCGTTGCAATAACCGTGAGTTTAAACTGCAAAAGCGTGAGTGTCGGGAAGTGTTTCTTTACGCGATCAAGAAGGCTTTGAACAAATACAATTTCAAGCTTTATGCTCTCTGTATCATGTCTAATCATGTCCATTACCTGATTGAACCTGCCCAACCCGAAGATTTACCTAAAATTATGCACTTTCTCAATTGGTACACGGCGATGTGTTTCAACCGTATGTTAAGGAGAACAGGACACTTTTGGGAAAAACGCTATTTTAGTGATGGCTTTCCTGCTTCAGACAAGGACAGGGCTTTAAATACCCTGCGCTACATTCACGGCAACCCGAAAGCGGCAAAAATGCGTTCTGGTTTCTTCTACGATTTCAGTAACTACGGCAGTTATGAACGTTTAACCGATGACGGTTTAACTCAATGGCATCCTGCTTTCCTACAACTAGGGAATAGTTTAGAAGACTGTGCCAAGAAATATAAAGGCTTTTGCCAAAGGTACAAACCGAAGGAGAAGAAGACCCCAACCCGATGCCATTGGGGTAGTAAGCTGTTGGCTGGGGTTCATCTATCAGAAAAAGGCTCTACCACCAACCCCCAAAAATCTAAGTCTGTGCTTACAAGCTATTACCAACCACTCACCCCCAAAAAATCTAAGTCTCGTCTTGTTCAAACCCCGTGCCAGGTATCCGAAAGCCCCGAACTGACTAGGATTGTGAGTCAATTCATAGAGGCTAACCGTGCGCCAAGGGAGACAGAAAAAGACTTTTGA	MPRKPRNLQSGYSYHITIRCNNREFKLQKRECREVFLYAIKKALNKYNFKLYALCIMSNHVHYLIEPAQPEDLPKIMHFLNWYTAMCFNRMLRRTGHFWEKRYFSDGFPASDKDRALNTLRYIHGNPKAAKMRSGFFYDFSNYGSYERLTDDGLTQWHPAFLQLGNSLEDCAKKYKGFCQRYKPKEKKTPTRCHWGSKLLAGVHLSEKGSTTNPQKSKSVLTSYYQPLTPKKSKSRLVQTPCQVSESPELTRIVSQFIEANRAPRETEKDF	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	40.94	gnl|BL_ORD_ID|1513|hsp_num:0	1643			591	789	polymyxin B
BGC0000479.1|Prenylagaramide_8 # 5655 # 5807 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.503	BGC0000479.1|Prenylagaramide_8 	5655	5807	-	Loose	750	22.7126	PAC-1	50.0	3005150	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	PAC beta-lactamase	ATGACTAAGAAAAACCTCAAACCCCAACAAGCCGCTCCTGTGCAACGGGAAATCAATACCACTTCCTCTGAGAGTGGTACAAGTACAGGTCTGACACCCCATCAGGCATACTTGGGAATCCCTTTACCTTTTGCGGGCGACGATGCGGAGTAA	MTKKNLKPQQAAPVQREINTTSSESGTSTGLTPHQAYLGIPLPFAGDDAE	MRCNKNVLSVVLLGALSLSAGNAFGQVSQADVDAVIRPLMSKYKIPGMAVALSVDGQHTFYNYGVASKATGQAVTPTTLFEIGSLSKTFTATLASYAQGQGKLQWSDQASHYLPSLKGSAFDRVTLLNLATHTSGMPLFVPDEVTNQEQLMAWYQAWQPTAPIGSQRVYSNLGIGMLGLITAQSLQKPFSEAMEQDLLAPLGMKHSWVKVPENQMAEYAQGYNKLDEPVRVTPGPPDAEAYGLKSSSADLLRWLDLNMAITPPSPAWQQAITETHKGYYQTGEFTQALIWEYYPWPTTKETLLAGNSSERIMKGLGAKPLTPPQAGPEQAWYNKTGSTNGFSTYAVFIPGQKTALILLANKWYPNDARIEAAYELVQRLKK	13.12	gnl|BL_ORD_ID|2857|hsp_num:0	3875			951	1029	
BGC0000479.1|Prenylagaramide_9 # 6095 # 6241 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.476	BGC0000479.1|Prenylagaramide_9 	6095	6241	-	Loose	750	22.7126	PAC-1	44.83	3005150	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	PAC beta-lactamase	ATGACTAAGAAAAACCTCAAACCCCAACAAGCCGCTCCTGTACAACGGGAAATCAATACCACTTCCTCTGAGAGTGGTACAAGTACAGGTCTGACACCCCATATTAACCCTTATTTGTACCCTTTTGCGGGCGACGATGCGGAGTAA	MTKKNLKPQQAAPVQREINTTSSESGTSTGLTPHINPYLYPFAGDDAE	MRCNKNVLSVVLLGALSLSAGNAFGQVSQADVDAVIRPLMSKYKIPGMAVALSVDGQHTFYNYGVASKATGQAVTPTTLFEIGSLSKTFTATLASYAQGQGKLQWSDQASHYLPSLKGSAFDRVTLLNLATHTSGMPLFVPDEVTNQEQLMAWYQAWQPTAPIGSQRVYSNLGIGMLGLITAQSLQKPFSEAMEQDLLAPLGMKHSWVKVPENQMAEYAQGYNKLDEPVRVTPGPPDAEAYGLKSSSADLLRWLDLNMAITPPSPAWQQAITETHKGYYQTGEFTQALIWEYYPWPTTKETLLAGNSSERIMKGLGAKPLTPPQAGPEQAWYNKTGSTNGFSTYAVFIPGQKTALILLANKWYPNDARIEAAYELVQRLKK	12.60	gnl|BL_ORD_ID|2857|hsp_num:0	3875			942	1029	
BGC0000479.1|Prenylagaramide_10 # 6405 # 6551 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.544	BGC0000479.1|Prenylagaramide_10 	6405	6551	-	Loose	1650	21.1718	Listeria monocytogenes mprF	33.33	3003770	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGACTAAGAAAAACCTCAAACCCCAACAAGCCGCTCCTGTGCAACGGGAAATCAATACCACTTCCTCTGAGGCTGGTACAGGGCTGACACCCCTTCGGAGTATAGGGGATTTCAGGCATCCTTTTGCGGGCGACGACGCGGAGTAG	MTKKNLKPQQAAPVQREINTTSSEAGTGLTPLRSIGDFRHPFAGDDAE	MKEKLMQAYAWFQKNSTVVKIVFITFVMAFVIFEIINIATGIDYPSLKENLTSQSPEQIFIMFIVGLIAVTPMLLYDYVIVKLLPGKFSPSHVIASGWITNTFTNIGGFGGVLGASLRASFYGKNASHKEILLAISKIALFLVSGLSIYCLVSLATLLIPGFADHFVNYWPWLLAGGLYFPILFTITKWKSKSLFVDLPIKRELTLIIASLLEWGFAFGCFAIIGTLMGEPVDIFKVFPLFVIASVIGIASMVPGGVGTFDVVMILGLSQLGVSQELALAWMLFYRIFYYIIPFVVGLLFFVQKAGKKVNDFLEGLPLLFLQKVAHRFLVIFVYGSGLLLILSSAVPNAIYHVPFLYKIMPFNFLFTSQITIVAFGFLLLGLARGIECKTKKAYIITVIVLGCAIFNTLARVFSMKQAIFLGIVLLCLFLARNEFYREKLVYTWSKVIIDSIIFIVCLAGYIVIGIYNSPNIKHSKEIPDYLRIASEHLWLVGFVGVFIAVVSLVIIYIYLSTTKEKLGSPFEAVKVREHLAKWGGNEVSHTMFLRDKLLFWAAEGEVLFSYRIIADKMVIMGEPTGNMDKMEAAIEEVMMNADRFGYRPVFYEVRGTMIPYLHDHGFDFIKLGEEGFVDVQNFTMSGKKKKGERALMNKLEREGYTFEIIEPPFNHDTWTTLRAVSDEWLDGREEKGFSLGFFDTYYLEQAPIAIAKNGEGTIVGFASMMPSYTDEMTSIDLMRYSKEAPSGIMDFLFINLFEKAKEDGFQTFNAGMAPLANVGESKYAFLGERLAGLVYRYSQGFYGFKGLRNFKSKYVTEWEQKFVAFRKRSSIAFTMLQLMILVGKKRPLANSQVVLDFPLEEETKKPDSE	5.55	gnl|BL_ORD_ID|2056|hsp_num:0	2279			2298	2352	defensin
BGC0000479.1|Prenylagaramide_13 # 7532 # 7789 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.341	BGC0000479.1|Prenylagaramide_13 	7532	7789	+	Loose	620	24.6386	ROB-10	25.58	3005080	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ROB beta-lactamase	ATGACGAAAATTCCTGAATTAATTTTTTTAGATACCAATGTTTATTTGATTGGCGCAGTTGAGCGACAAAGCCCTGAAGGTTTAATTCTAAAATGGTTAGGTTGGGAAGCCCCAAACGATAATTCTGTGGGGGTAATAATTTCTGAAGAACTTATTGATCAAATTGCCAGAGTTGCTAATTTACAAAGTATTGGTTTAATCTTTCCCATTGAGTCCGTTTATGAGGATATTATTTTTGAGGAATTAGGAACAAACTAG	MTKIPELIFLDTNVYLIGAVERQSPEGLILKWLGWEAPNDNSVGVIISEELIDQIARVANLQSIGLIFPIESVYEDIIFEELGTN	MFNKLKIGTLLLLTLTACSPNSVHSVTSNPQPASAPVQQSATQATFQQTLANLEQQYQARIGVYVWDTETGHSLSYRADERFAYASTFKALLAGAVLQSLPEKDLNRTISYSQKDLVSYSPETQKYVGKGMTIAQLCEAAVRFSDNSATNLLLKELGGVEQYQRILRQLGDNVTHANRLEPDLNQAKPNDIRDTSTPKQMAMNLNAYLLGNTLTESQKTILWNWLDNNATGNPLIRAATPTSWKVYDKSGAGKYGVRNDIAVVRIPNRKPIVMAIMSTQFTEEAKFNNKLVEDAAKQVFHTLQLN	27.87	gnl|BL_ORD_ID|2798|hsp_num:0	3816			579	693	
BGC0000479.1|Prenylagaramide_14 # 8087 # 8314 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.329	BGC0000479.1|Prenylagaramide_14 	8087	8314	+	Loose	600	22.3274	vanS gene in vanP cluster	42.31	3007192	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGACTCATTTACTAGAAAAAGCATTCCAAGAAGCTCAAAAACTCTCAAATTATCTTCAGGATGAACTTGCACAACAATTACTCGAAGATATCGAGAATGAGTTAAAATGGCAAGAAAGTTTATCTAATCCAGATATGGATTTAGGTATTTTTCAAGAAATGGCTCAGTTAGCATTACTTGAAGATGAAGAAGGTAAGACTGAAGATAAGGGTTTTGGTGAGAAATAA	MTHLLEKAFQEAQKLSNYLQDELAQQLLEDIENELKWQESLSNPDMDLGIFQEMAQLALLEDEEGKTEDKGFGEK	MNKRLKKSISRYFFIRFLQGLCCMSFFLVFALGISYLWCSERVWYEGEVSYFIVHILHEYWYVLFLGLMIIGCIVIAMINIRCIAQGISDIMQAVRDVNEENEVQIELPDYLADAQAQLTDIKNHVEWNKKTAQEAVQRKNDLIMYLAHDLKTPLTSTIGYLTLLHDEKEISKEVRDKYMGIALKKSLRLEELLNEFFEIARFNFSTMVLEKGNVNMSVMVEQLLYEFKPLFDKKGLTYTIDLEKDVNVYCDVEKMERVFDNLLKNIVNYSYENTEIAITLKANGEQGMLFVIRNHGKTIPKEKCERIFEQFYRLDGSRGTKTGGSGLGLAVVKEIVELHEGTVTCESENEEICFRITI	20.89	gnl|BL_ORD_ID|4822|hsp_num:0	5808			318	390	vancomycin; teicoplanin
BGC0000479.1|Prenylagaramide_15 # 8314 # 8589 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.330	BGC0000479.1|Prenylagaramide_15 	8314	8589	+	Loose	375	22.3274	tmrB	33.33	3003059	protein homolog model	n/a	n/a	nucleoside antibiotic	reduced permeability to antibiotic	tunicamycin resistance protein	ATGCGATCATCAAGAACTAGAAGTTTTAGAAAATTATTTACAGTATTACCTCAAAGAATCAAAGAAACTTCCTATAAAAATTATGAGCTTTGGAAAGAAAATCCATTTCATCCGAGTTTAGAGTTTAAGAAAGTCAAACCCAAAGAAAATATTTGGTCAGTTAGAGTAGGAATCGGATGGAGAGCATTGGGAGTAATGAAACCCAATGAAGACAAGATAGTTTGGTTTTGGATTGGTTCTCATGCTGAGTACGATAAAATTCTTGGTACGAAATAA	MRSSRTRSFRKLFTVLPQRIKETSYKNYELWKENPFHPSLEFKKVKPKENIWSVRVGIGWRALGVMKPNEDKIVWFWIGSHAEYDKILGTK	MIIWINGAFGSGKTQTAFELHRRLNPSYVYDPEKMGFALRSMVPQEIAKDDFQSYPLWRAFNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKRLRTRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRGSLRRFADRLMVKLNHIRIK	46.19	gnl|BL_ORD_ID|1654|hsp_num:0	1794			114	177	tunicamycin
BGC0000479.1|Prenylagaramide_16 # 8831 # 9121 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.354	BGC0000479.1|Prenylagaramide_16 	8831	9121	-	Loose	500	22.7126	APH(3')-IIc	70.0	3002646	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGAACGAAAATATTATGAGCAATATATCAAAAACAGATTGGAATAGAATTGATGCGATGAAAGATGAGGATATTGATACTTCTGATATTCCTCCCCTGTCAGAAGGTTTTTGGACTAAAGCACAATTGCGAATCCCTAAGCCTCCTGTTACTGTAGAAGTTGAAGTAGATTCAGAAACTTTTGCCTGGTTTCAAGCACAAGGAGAAACTGCTCCAAAACAAATGTCTGTAGCGTTGAAAATTTATGTCCAAGCAAATAAGGCTTTTTCTTCATCTACAAGTAATATTTAG	MNENIMSNISKTDWNRIDAMKDEDIDTSDIPPLSEGFWTKAQLRIPKPPVTVEVEVDSETFAWFQAQGETAPKQMSVALKIYVQANKAFSSSTSNI	MEASNPFTDGLRLPRAWQEALADAHIERQSIGVSRADVARVHRPGQTDAFLKSEVIDAFSELGDEIARLRWLQAQGQSAPTVIATTEEGGRRWLLMSALPGRDLASSPELAPRRVAELLADALRGLHAVPVANCPFDQQLASRLQAAQARVEAGLVDADDFDDERLGQSPQQVFAELRATRPAHEDLVVSQGDACLPNLTVTDGRFTGFIDCGRLGVADRYQDLALAARSLVHNFGESRCVAALFQRYGAVPDERRLAFYRLLDEFF	35.96	gnl|BL_ORD_ID|939|hsp_num:0	1018			210	240	neomycin; ribostamycin; butirosin; kanamycin A; gentamicin B; paromomycin; gentamicin
BGC0000479.1|Prenylagaramide_17 # 9075 # 9362 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.333	BGC0000479.1|Prenylagaramide_17 	9075	9362	-	Loose	550	24.2534	OXA-308	22.06	3001763	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAATTTGAATGGGATGAGGGCAAAAACCAAACTAACCTTATCAAACATGGATTTGACTTTACAGATGCTTATCGTATCTTTAACCTACCAATGGTTGTTGAATTGGATGAGCGAGAGAATTATAGAGAAGATCGCTTTGTTGCTATTGGTTTACTAGATGGACGAGTTGTGGTTATTGTCTATACTGAACCTGATGATCAAACGATTCGTATTATATCTTTAAGAAAAGCATTATCTTATGAACGAAAATATTATGAGCAATATATCAAAAACAGATTGGAATAG	MKFEWDEGKNQTNLIKHGFDFTDAYRIFNLPMVVELDERENYREDRFVAIGLLDGRVVVIVYTEPDDQTIRIISLRKALSYERKYYEQYIKNRLE	MNKKLNLALLCFLSILCAACQSNQQLSANSHTENHNTRAAEISLLFDEMHTQAVFVTYDGQHFQSYGNALQRADTAYVPASTFKMLNALIGLQNHKATNTEVFKWDGQKRAMSIWEKDMTLSDAMKVSAVPVYQELARRIGLDLMQKEVTRVRYGNTDIGTVVDRFWLDGPLKITPKQEAQFAYQLATQQLPFDQNVQSQVKDMLYVESRGQSKLFAKSGLSMKNGQPDIGWYTGWVEQADGKIVAFSINMQMVQGLDVNSRQQATLDILDKLGIFFYL	34.05	gnl|BL_ORD_ID|2562|hsp_num:0	3470			306	486	cloxacillin; oxacillin; cefalotin
BGC0000479.1|Prenylagaramide_18 # 9616 # 9852 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.515	BGC0000479.1|Prenylagaramide_18 	9616	9852	-	Loose	550	25.7942	BEL-4	35.14	3006154	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	BEL beta-lactamase	ATGACTAAGAAAAACCTCAAACCCCAACAAGCCGCACCCGTACAACGGGAAAATACCGCAACTGTGGCTCGCGCAACTGTGGCTCGTGATGGTGCGATCGCACCTTCTTCGTGGCTCAGTATGGGTAGAAAGGGAAGTTCCTTTTGCGGGCGACGACGCAGAGTAATCCCCTTGATTCTAACACTCACCTCAAAAAGTGTCAAAAGTCTTTTTCTGTCTCCCTTGGCGCACGGTTAG	MTKKNLKPQQAAPVQRENTATVARATVARDGAIAPSSWLSMGRKGSSFCGRRRRVIPLILTLTSKSVKSLFLSPLAHG	MKLLLYPLLLFLVIPAFAQADFEHAISDLEAHNQAKIGVALVSENGNLIQGYRANERFAMCSTFKLPLAALVLSRIDAGEENPERKLHYDSAFLEEYAPAAKRYVATGYMTVTEAIQSALQLSDNAAANLLLKEVGGPPLLTKYFRSLGDKVSRLDRIEPTLNTNTPGDERDATTPMSMAQTVSKLIFGDTLTYKSKGQLRRLLIGNQTGDKTIRAGLPDSWVTGDKTGSCANGGRNDVAFFITTAGKKYVLSVYTNAPELQGEERALLIASVAKLARQYVVH	27.56	gnl|BL_ORD_ID|3299|hsp_num:0	4368			654	765	
BGC0000479.1|Prenylagaramide_19 # 10031 # 10615 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.366	BGC0000479.1|Prenylagaramide_19 	10031	10615	+	Loose	200	25.0238	vanT gene in vanN cluster	33.33	3002975	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGATTGCTGTAAAAGGTAAGTTTCCTAAGTTAACACCCGAAGAATATTTTATTTGGGAAGAAAAACAACTGCTGCGCCATGAGTATCTTAGTGGTAGAGTTTATGCCATGAGTGGAGGGACTCAAAATCATGGGCGAATTGCTAGTAATATTATTTTCATCCTTAAAGGTCATTTACGGGGCGGTGGTTGTCAGGTAGGTAATTCCGATTGTCGTGTAAATATTTTTGAAACTAAAGATTATGTTTATCCTGATGTGAGCGTTACTTGTGATGAGCGCGATCGCACTGCAATTCAGGCGATTCAATATCCTTGTCTAATTATTGAGGTTTTATCTGCAAGTACAGCCAATTATGACCGAGGGGATAAATTTAGGATGTATCGTCGCAATCCTAGTTTGCAAGATTATGTTTTAGTTGATGCCGAGAAAATAGCGATCGATTTATACCGCAAAAATGATCGTGGTAATTGGGAAATTTTTAATTATCAATCGGGGGATAATATTGATTTACAAAGTATTGGTTTAATCTTTCCCATTGAGTCCGTTTATGAGGATATTATTTTTGAGGAATTAGGAACAAACTAG	MIAVKGKFPKLTPEEYFIWEEKQLLRHEYLSGRVYAMSGGTQNHGRIASNIIFILKGHLRGGGCQVGNSDCRVNIFETKDYVYPDVSVTCDERDRTAIQAIQYPCLIIEVLSASTANYDRGDKFRMYRRNPSLQDYVLVDAEKIAIDLYRKNDRGNWEIFNYQSGDNIDLQSIGLIFPIESVYEDIIFEELGTN	MKNVNTGINQFRLIAAFMVVAIHCFPFQSFSKTLDILITLTLFRTAVPFFLMVTGFYLIGPIATKRGYPAYLKIKKFLKKQVKLYVLATLIYLPLAFYSGVITFKTSVIQFFQLIFFEGVLYHLWYFPALILGVLIVYCLLQRFTLRQVLLVTFLFYLLCLGGDSWWGLARQIPVLEKSYQGIFTLMIHTRNGLFFAPFFLTLGASFHQSEWNMRTSKAKYFLLIASLGMLVESYLLHSFSSPKHDSAYLFLPVVMFFLFPLILNWQPTRVIADASTISLGIYVLHPYVIAVVHTLAKKITILNNSLIYYLCVSLLTSLIILYVHSKKKKTTKNQATFVPRTKKVLSKQAVIHNLAQINQVIPKTTKIMAVIKANAYGTDDTEFARILEQQGVDFFAVATIDEGIRLRENGIKSKILILGYTPSIRIKELAHYTLIQTIVSKEHAYSLNQQKIPISCHLKIDTGMHRLGVEPVVQEVSSLYRLPYLNIQGIYSHLGSADDRSDKGMKRTRKQISIFDYLLHELELQKIDVGVTHLQSSYGILNYPELVYDYVRPGILLYGYLSEHNGDSKINLNLQPILDVQALLVSKKWVAAGEYLGYSLDTKLVSPKLIGIVSIGYADGVPRELSHNEFYLAYQGQNLPQIGRICMDMLLVDLTDSPEIKVESQISIFPELEQTANQTNTLTNEIISRLGNRFYTEWS	27.71	gnl|BL_ORD_ID|4745|hsp_num:0	1983			1497	1632	vancomycin
BGC0000479.1|Prenylagaramide_20 # 10710 # 10835 # 1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.421	BGC0000479.1|Prenylagaramide_20 	10710	10835	+	Loose	500	21.1718	CRH-1	57.14	3006865	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CRH beta-lactamase	GTGCCAGGTATCCGAAAGCCCCAAGAAGCACTAGAAAACGCGAAGGAAGTTTTAGAAGATTTAGTGTATGGTTATGAGCAAATAGGGAAAATTTTGCCAGAACCAAAGACATTACAGGTCGCTTGA	MPGIRKPQEALENAKEVLEDLVYGYEQIGKILPEPKTLQVA	MFKHLILFASLAAPLTQAVAADPLAVAADKLAKLERDFGGSIGVYAIDTGSGATVANRPNERFPMCSSFKGFLAAGVLAQSQDKPGLLDKRIRYSKAALPNWSPITTKHQASGMTVAELNAASVQYSDNGAANLLLKEINGPAALTAFMRSIGDASFRLDRREPELNSAIPGDPRDTSTPKAVAESAQKLALGKALPEPQRQQLADWLKGNTTGNARIRAAVPAGWEVGDKTGTCGVYGTANDFAVIWPPKRAPIVLAVYTKHAKKEAKHSDEVIAAAARAALEAFNVKK	14.14	gnl|BL_ORD_ID|3412|hsp_num:0	4481			573	615	
BGC0000479.1|Prenylagaramide_21 # 10852 # 11001 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.427	BGC0000479.1|Prenylagaramide_21 	10852	11001	+	Loose	900	21.9422	lmrB	41.38	3002813	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTTGCTCCTTATTCCCCCCTTAGTAATAGTGGCTAAAGTTGCTTATTATTCCCCCTTACTAAAGATGATTAAAAGTGCTGTGCTTATTATTCCCCCCTTACTAAGGGGGGCTAGGGGGGTAGAAACTCAGGTGAGTGCTAAGGATTAA	MLLLIPPLVIVAKVAYYSPLLKMIKSAVLIIPPLLRGARGVETQVSAKD	METTAKASQQYKVMPIMISLLLAGFIGMFSETALNIALTDLMKELNITAATVQWLTTGYLLVLGILVPVSGLLLQWFTTRQLFTVSLIFSILGTFIAALAPSFSFLLAARIVQALGTGLLLPLMFNTILVIFPPHKRGAAMGTIGLVIMFAPAIGPTFSGLVLEHLNWHWIFWISLPFLVLALVFGIAYMQNVSETTKPKIDVLSIILSTIGFGGIVFGFSNAGEGSGGWSSPTVIVSLIVGVVGLILFSIRQLTMKQPMMNLRAFKYPMFILGVIMVFICMMVILSSMLLLPMYLQGGLVLTAFASGLVLLPGGILNGFMSPVTGRLFDKYGPKWLVIPGFVIVTVVLWFFSNVTTTSTAVLIIILHTCLMIGISMIMMPAQTNGLNQLPREFYPDGTAIMNTLQQMAGAIGTAVAVSIMAAGQHDYMSTVKNPADPAVIPQALTAGVQHAFVFAMIVAIIGLIGAFFMKRVKVDH	10.27	gnl|BL_ORD_ID|540|hsp_num:0	592			1008	1095	
